Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Nov 5, 2021

Accession no.
0001209191-21-063235
Filed
Nov 5, 2021
Trade date
Oct 1-29, 2021
Filing delay
35 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $8.11K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockPPurchaseAcquired+142$2.69+$381.9840,937Direct
Oct 4, 2021Common StockPPurchaseAcquired+142$2.87+$407.5441,079Direct
Oct 5, 2021Common StockPPurchaseAcquired+142$2.82+$400.4441,221Direct
Oct 6, 2021Common StockPPurchaseAcquired+142$2.76+$391.9241,363Direct
Oct 7, 2021Common StockPPurchaseAcquired+142$2.76+$391.9241,505Direct
Oct 8, 2021Common StockPPurchaseAcquired+142$2.84+$403.2841,647Direct
Oct 11, 2021Common StockPPurchaseAcquired+142$2.73+$387.6641,789Direct
Oct 12, 2021Common StockPPurchaseAcquired+142$2.71+$384.8241,931Direct
Oct 13, 2021Common StockPPurchaseAcquired+142$2.71+$384.8242,073Direct
Oct 14, 2021Common StockPPurchaseAcquired+142$2.81+$399.0242,215Direct
Oct 15, 2021Common StockPPurchaseAcquired+142$2.76+$391.9242,357Direct
Oct 18, 2021Common StockPPurchaseAcquired+142$2.75+$390.542,499Direct
Oct 19, 2021Common StockPPurchaseAcquired+142$2.76+$391.9242,641Direct
Oct 20, 2021Common StockPPurchaseAcquired+142$2.63+$373.4642,783Direct
Oct 21, 2021Common StockPPurchaseAcquired+142$2.65+$376.342,925Direct
Oct 22, 2021Common StockPPurchaseAcquired+142$2.66+$377.7243,067Direct
Oct 25, 2021Common StockPPurchaseAcquired+142$2.64+$374.8843,209Direct
Oct 26, 2021Common StockPPurchaseAcquired+142$2.64+$374.8843,351Direct
Oct 27, 2021Common StockPPurchaseAcquired+142$2.61+$370.6243,493Direct
Oct 28, 2021Common StockPPurchaseAcquired+142$2.61+$370.6243,635Direct
Oct 29, 2021Common StockPPurchaseAcquired+142$2.72+$386.2443,777Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)